Meanwhile, the expression of chemokine CXCL12 is strongly correlated with overall survival in OSA (21), and targeting CXCL12 derived from FAP-positive TAFs enhances the sensitivity of tumors to immunotherapy (22). Here, FAP is linked to obstructive sleep apnea syndrome.